tiprankstipranks
Trending News
More News >
Bioharvest Sciences, Inc. (BHST)
:BHST
US Market
Advertisement

BioHarvest Sciences (BHST) Earnings Dates, Call Summary & Reports

Compare
33 Followers

Earnings Data

Report Date
Dec 01, 2025
TBA (Not Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-0.12
Last Year’s EPS
-0.16
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 11, 2025|
% Change Since: -1.02%|
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, gross margin expansion, and success in both product and CDMO divisions, indicating strong operational momentum. However, increased operating expenses and net losses present challenges. The launch of new products and strategic programs, such as the Health Pros' Affiliate program, are positive indicators for future growth.
Company Guidance -
Q3 2025
In the BioHarvest Sciences Second Quarter 2025 Corporate Update Conference Call, the company provided significant guidance and metrics indicating strong performance and strategic milestones. Revenue for Q2 2025 rose by 41% year-over-year to $8.5 million, driven by growth in VINIA subscription revenue and CDMO services. Gross margins expanded by 800 basis points to 60%, up from 52% in the same quarter the previous year, attributed to the deployment of larger bioreactors and improved manufacturing efficiencies. The company aims to reach adjusted EBITDA breakeven by Q4 2025, propelled by a diverse strategy including new product launches such as VINIA Daily 2X Formula chews and the upcoming VINIA Blood Flow Hydration Solution. The CDMO division achieved a milestone with a research contract advancing to Stage 2, contributing positively to the company's financials. The Health Pros' Professional Affiliate program is expected to significantly enhance VINIA's market exposure, targeting 300 influencers by year-end. Despite a net loss of $4 million in Q2 2025, the company is optimistic about reaching profitability, supported by a disciplined approach to cost management and strategic growth initiatives.
Revenue Growth
Revenue rose 41% year-over-year to $8.5 million, in line with guidance, driven by performance across vinia.com, Amazon, and CDMO services.
Gross Margin Expansion
Gross margins expanded by 800 basis points to 60%, up from 52% in the same year-ago quarter, driven by larger bioreactors, enhanced manufacturing yields, and digitization of workflows.
VINIA Product Success
Total active VINIA customers in the U.S. reached approximately 65,000, with Amazon sales accounting for 20% of total sales. VINIA is the #1 resveratrol-only product sold on Amazon in the U.S.
CDMO Milestones
Successfully completed Stage 1 of a CDMO research contract, advancing to Stage 2 with a pharmaceutical partner. Signed a new contract targeting a fragrance molecule.
New Product Launches
Launched VINIA Daily 2X Formula chews and expanded VINIA Inside delivery systems with new SuperFood Tea SKUs. Preparing to launch VINIA Blood Flow Hydration Solution in October.
Health Pros' Affiliate Program
Announced the launch of the VINIA Health Pros' Professional Affiliate program to activate health practitioners and influencers, aiming for significant subscriber growth.

BioHarvest Sciences (BHST) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BHST Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Dec 01, 2025
2025 (Q3)
-0.12 / -
-0.16
Aug 11, 2025
2025 (Q2)
-0.11 / -0.24
-0.04-500.00% (-0.20)
May 15, 2025
2025 (Q1)
- / -0.13
-0.4872.92% (+0.35)
Mar 31, 2025
2024 (Q4)
-0.12 / -0.13
-0.4872.92% (+0.35)
Nov 25, 2024
2024 (Q3)
-0.05 / -0.16
-0.129-24.03% (-0.03)
Aug 29, 2024
2024 (Q2)
-0.10 / -0.04
-0.21281.13% (+0.17)
May 30, 2024
2024 (Q1)
- / -
-0.056
Apr 30, 2024
2023 (Q4)
- / -0.48
-0.056-757.14% (-0.42)
Nov 29, 2023
2023 (Q3)
- / -0.13
-0.357.00% (+0.17)
Aug 29, 2023
2023 (Q2)
- / -0.21
-0.183-15.85% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BHST Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 11, 2025
$8.76$8.82+0.68%
May 15, 2025
$6.43$6.50+1.09%
Mar 31, 2025
$6.19$6.49+4.85%
Nov 25, 2024
$6.30$6.18-1.90%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bioharvest Sciences, Inc. (BHST) report earnings?
Bioharvest Sciences, Inc. (BHST) is schdueled to report earning on Dec 01, 2025, TBA (Not Confirmed).
    What is Bioharvest Sciences, Inc. (BHST) earnings time?
    Bioharvest Sciences, Inc. (BHST) earnings time is at Dec 01, 2025, TBA (Not Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BHST EPS forecast?
          BHST EPS forecast for the fiscal quarter 2025 (Q3) is -0.12.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis